Gut microbiota modulate T cell trafficking into human colorectal cancer
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Objective: Tumour-infiltrating lymphocytes (TILs) favour survival in human colorectal cancer (CRC). Chemotactic factors underlying their recruitment remain undefined. We investigated chemokines attracting T cells into human CRCs, their cellular sources and microenvironmental triggers. Design: Expression of genes encoding immune cell markers, chemokines and bacterial 16S ribosomal RNA (16SrRNA) was assessed by quantitative reverse transcription-PCR in fresh CRC samples and corresponding tumour-free tissues. Chemokine receptor expression on TILs was evaluated by flow cytometry on cell suspensions from digested tissues. Chemokine production by CRC cells was evaluated in vitro and in vivo, on generation of intraperitoneal or intracecal tumour xenografts in immune-deficient mice. T cell trafficking was assessed on adoptive transfer of human TILs into tumour-bearing mice. Gut flora composition was analysed by 16SrRNA sequencing. Results: CRC infiltration by distinct T cell subsets was associated with defined chemokine gene signatures, including CCL5, CXCL9 and CXCL10 for cytotoxic T lymphocytes and T-helper (Th)1 cells; CCL17, CCL22 and CXCL12 for Th1 and regulatory T cells; CXCL13 for follicular Th cells; and CCL20 and CCL17 for interleukin (IL)-17-producing Th cells. These chemokines were expressed by tumour cells on exposure to gut bacteria in vitro and in vivo. Their expression was significantly higher in intracecal than in intraperitoneal xenografts and was dramatically reduced by antibiotic treatment of tumour-bearing mice. In clinical samples, abundance of defined bacteria correlated with high chemokine expression, enhanced T cell infiltration and improved survival. Conclusions: Gut microbiota stimulate chemokine production by CRC cells, thus favouring recruitment of beneficial T cells into tumour tissues.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Both CXCL9 and CXCL10, known as important for cytotoxic T cell and T helper 1 cell recruitment, can reportedly be upregulated by gut microbiota in patients with colorectal cancer31.”
From Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial (2022) · cites this paper as [31]
In the citing paper
“The i.c. models showed a striking 70-fold higher level of CCL5, 19-fold higher level of CCL20, and 12-fold higher level of CXCL10 levels than those in i.p. xenografts, suggesting that exposure to gut flora resulted in a strong induction of chemokine expression.”
From Gut Microbiome as a Potential Factor for Modulating Resistance to Cancer Immunotherapy (2020) · cites this paper as [117]
In the citing paper
“Cremonesi et al. (117) found that exposing colorectal cancer (CRC) cells to Fusobacterium nucleatum, B. fragilis, and E. coli could upregulate the majority of chemokine genes both in vitro and in vivo.”
From Gut Microbiome as a Potential Factor for Modulating Resistance to Cancer Immunotherapy (2020) · cites this paper as [117]
In the citing paper
“To summarize, gut microbiota may play a role in enhancing T-cell recruitment into the tumor site, thereby promoting the cytotoxic effect of effector immune cells toward target tumor cells to improve the clinical treatment outcome in patients.”
From Gut Microbiome as a Potential Factor for Modulating Resistance to Cancer Immunotherapy (2020) · cites this paper as [117]
In the citing paper
“The migration of TILs into i.c. tumors enhanced the secretion of chemokines into the TME.”
From Gut Microbiome as a Potential Factor for Modulating Resistance to Cancer Immunotherapy (2020) · cites this paper as [117]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
Galon, J., Costes, A., Sanchez-Cabo, F., Kirilovsky, A., Mlecnik, B., Lagorce-Pagès, C., Tosolini, M., Camus, M., Berger, A., Wind, P., et al. (2006) · Science · doi:10.1126/science.1129139 · Cited by 6,516
The immune contexture in human tumours: impact on clinical outcome
Fridman, W. H., Pagès, F., Sautès-Fridman, C., & Galon, J. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3245 · Cited by 4,981
Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
Bindea, G., Mlecnik, B., Tosolini, M., Kirilovsky, A., Waldner, M., Obenauf, A. C., Angell, H., Fredriksen, T., Lafontaine, L., Berger, A., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.10.003 · Cited by 4,422
Rubinstein, M. R., Wang, X., Liu, W., Hao, Y., Cai, G., & Han, Y. W. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.07.012 · Cited by 2,476
Intestinal inflammation targets cancer-inducing activity of the microbiota
Arthur, J. C., Perez-Chanona, E., Mühlbauer, M., Tomkovich, S., Uronis, J. M., Fan, T.-J., Campbell, B. J., Abujamel, T., Dogan, B., Rogers, A. B., et al. (2012) · Science · doi:10.1126/science.1224820 · Cited by 2,263
Effector Memory T Cells, Early Metastasis, and Survival in Colorectal Cancer
Pagès, F., Berger, A., Camus, M., Sanchez-Cabo, F., Costes, A., Molidor, R., Mlecnik, B., Kirilovsky, A., Nilsson, M., Damotte, D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051424 · Cited by 2,135
Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma
Castellarin, M., Warren, R. L., Freeman, J. D., Dreolini, L., Krzywinski, M., Strauss, J., Barnes, R., Watson, P., Allen-Vercoe, E., Moore, R. A., et al. (2012) · Genome Research · doi:10.1101/gr.126516.111 · Cited by 2,043
Genomic analysis identifies association of Fusobacterium with colorectal carcinoma
Kostic, A. D., Gevers, D., Pedamallu, C. S., Michaud, M., Duke, F., Earl, A. M., Ojesina, A. I., Jung, J., Bass, A. J., Tabernero, J., et al. (2012) · Genome Research · doi:10.1101/gr.126573.111 · Cited by 1,960
Spranger, S., Spaapen, R. M., Zha, Y., Williams, J., Meng, Y., Ha, T. T., & Gajewski, T. F. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006504 · Cited by 1,677
Gur, C., Ibrahim, Y., Isaacson, B., Yamin, R., Abed, J., Gamliel, M., Enk, J., Bar-On, Y., Stanietsky-Kaynan, N., Coppenhagen-Glazer, S., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.01.010 · Cited by 1,490
Cited by
Human gut microbiome: Hopes, threats and promises
Cani, P. D. (2018) · Gut · doi:10.1136/gutjnl-2018-316723 · Cited by 1,386
Gut microbiota in colorectal cancer: mechanisms of action and clinical applications
Wong, S. H., & Yu, J. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0209-8 · Cited by 1,331
The Intestinal Microbiota and Colorectal Cancer
Cheng, Y., Ling, Z., & Li, L. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.615056 · Cited by 582
Tumor Immunology and Tumor Evolution: Intertwined Histories
Galon, J., & Bruni, D. (2020) · Immunity · doi:10.1016/j.immuni.2019.12.018 · Cited by 540
Turning cold tumors hot: from molecular mechanisms to clinical applications
Zhang, J., Huang, D., Saw, P. E., & Song, E. (2022) · Trends in Immunology · doi:10.1016/j.it.2022.04.010 · Cited by 534
Metadata
- Authors
- Cremonesi, E., Governa, V., Garzon, J. F. G., Mele, V., Amicarella, F., Muraro, M. G., Trella, E., Galati-Fournier, V., Oertli, D., Däster, S. R., Droeser, R. A., Weixler, B., Bolli, M., Rosso, R., Nitsche, U., Khanna, N., Egli, A., Keck, S., Slotta-Huspenina, J., Terracciano, L. M., Zajac, P., Spagnoli, G. C., Eppenberger-Castori, S., Janssen, K.-P., Borsig, L., & Iezzi, G.
- Affiliations
- University of Basel (CH)
- University of Zurich (CH)
- Pediatric Surgery, University Children’s Hospital, University of Basel, Basel, Switzerland
- University Hospital of Basel (CH)
- St. Claraspital (CH)
- Department of Visceral Surgery, Ospedale Civico Lugano, Lugano, Switzerland
- TUM Klinikum (DE)
- Institute of Pathology, Technical University of Munich, Munich, Germany
- Institute of Pathology, University of Basel, Basel, Switzerland
- Corresponding author
- Iezzi, Giandomenica
- ORCID
- Governa, Valeria
- Garzon, Jesus Francisco Glaus
- Mele, Valentina
- Amicarella, Francesca
- Muraro, Manuele Giuseppe
- Oertli, Daniel
- Däster, Silvio Raffael
- Droeser, Raoul A
- Weixler, Benjamin
- Bolli, Martin
- Nitsche, Ulrich
- Khanna, Nina
- Egli, Adrian
- Keck, Simone
- Terracciano, Luigi M
- Zajac, Paul
- Spagnoli, Giulio Cesare
- Janssen, Klaus-Peter
- Borsig, Lubor
- Iezzi, Giandomenica
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2018-02-06
- Volume
- 67
- Issue
- 11
- Pages
- 1984-1994
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W2786828634
- Cited by
- 275
- References
- 28
- Citations by year
- 2026: 17 · 2025: 31 · 2024: 34 · 2023: 56 · 2022: 36 · 2021: 32 · 2020: 35 · 2019: 25 · 2018: 9
- FWCI
- 9.49
- Type
- journal article
- Language
- en
- Open access
- green
- www.zora.uzh.ch
- Licence
- other-oa
- Locations
- Gut (publishedVersion)
- PubMed (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, other-oa)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- HighWire Press Open Archive (submittedVersion)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich)
- Funders
- Universität Basel
- Swiss National Science Foundation
- Department of Surgery, University Hospital Basel
- Topics
- Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Keywords
- colorectal cancer, gut microbiota, tumor-infiltrating lymphocytes, T cell migration, chemokines, chemokine receptors, CCL20, CCL17, CCL22, CXCL12, CXCL13, CXCL9, CXCL10, RANTES, regulatory T cells, Th1 cells, IL-17, tumor microenvironment, antibiotic therapy, tumor xenografts, 16S rRNA
- MeSH terms
- Gastrointestinal Microbiome, Adult, Aged, Aged, 80 and over, Animals, Female, Flow Cytometry, Fluorescent Antibody Technique, Humans, Male, Middle Aged, RNA, Ribosomal, 16S, Colorectal Neoplasms, Biomarkers, Lymphocytes, Tumor-Infiltrating, In Situ Hybridization, Chemokines, Cell Line, Tumor, Mice, Real-Time Polymerase Chain Reaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Gut microbiota modulate T cell trafficking into human colorectal cancer. https://app.cochat.ai/papers/10.1136/gutjnl-2016-313498
- The paper
- Cremonesi, E., Governa, V., Garzon, J. F. G., Mele, V., Amicarella, F., Muraro, M. G., Trella, E., Galati-Fournier, V., Oertli, D., Däster, S. R., Droeser, R. A., Weixler, B., Bolli, M., Rosso, R., Nitsche, U., Khanna, N., Egli, A., Keck, S., Slotta-Huspenina, J., . . . Iezzi, G. (2018). Gut microbiota modulate T cell trafficking into human colorectal cancer. Gut. https://doi.org/10.1136/gutjnl-2016-313498
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.